BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Events - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://events.ucsc.edu
X-WR-CALDESC:Events for Events
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260312T114000
DTEND;TZID=America/Los_Angeles:20260312T131500
DTSTAMP:20260417T185825
CREATED:20260303T000204Z
LAST-MODIFIED:20260303T000204Z
UID:10009382-1773315600-1773321300@events.ucsc.edu
SUMMARY:BME 280B Seminar: Modulating Insulin Receptor Through New Ligands
DESCRIPTION:Presenter: Danny Chou\, Associate Professor of Pediatrics\, Stanford University \nDescription: Since its discovery in 1921\, insulin has been at the forefront of scientific breakthroughs. From its amino acid sequencing to the revelation of its three‐dimensional structure\, the progress in insulin research has spurred significant therapeutic breakthroughs. In recent years\, protein engineering has introduced innovative chemical and enzymatic methods for insulin modification\, fostering the development of therapeutics with tailored pharmacological profiles. In this seminar\, I will highlight the use of new ligands to modulate insulin receptors and discuss how they continue to shape the future trajectory of insulin research. \nBio: Danny Chou is an Associate Professor of Pediatrics and by courtesy\, of Chemical & Systems Biology at Stanford University. He is an affinity group leader at Stanford Diabetes Research Center. His research interests lie in the intersection of peptide therapeutics and metabolic diseases. He started his independent career as an assistant professor of biochemistry at University of Utah in 2014. He moved his lab to Stanford University in 2020 and continued their pursuit of using peptide and protein chemistry to develop therapeutics to address unmet needs.  \nHosted by: Professor Andy Yeh\, BME Department
URL:https://events.ucsc.edu/event/bme-280b-seminar-modulating-insulin-receptor-through-new-ligands/
LOCATION:Physical Sciences Building\, Physical Sciences Building\, Santa Cruz\, CA\, 95064
CATEGORIES:Lectures & Presentations,Seminars
ATTACH;FMTTYPE=image/png:https://events.ucsc.edu/wp-content/uploads/2026/02/BElogoWHITE.png
GEO:36.9996638;-122.0618552
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=Physical Sciences Building Physical Sciences Building Santa Cruz CA 95064;X-APPLE-RADIUS=500;X-TITLE=Physical Sciences Building:geo:-122.0618552,36.9996638
END:VEVENT
END:VCALENDAR